4DS MEMORY LIMITED — Director's Dealing 2016

Jul 17, 2016

Appendix 3Y Change of Director’s Interest Notice

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Introduced 30/9/2001.
Name of entity	4DS Memory Limited
ABN	43 145 590 110

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director
		Mr David McAuliffe
Date of last notice
		10 December 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest
		Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest.
		Concept Biotech PtDavid Jerimiah Mc(trustee and benefi	y Ltd (director related entity)Auliffe ciary)
Date of change
		15 July 2016
No. of securities held priorto change		Direct
		David McAuliffe840,825 fully paid	Ordinary Shares escrowed until 17/12/2017
		156,763 Class 1 PeIndirect	rformance Shares escrowed until 17/2/2017
		Concept Biotech Pt	y Ltdd Ordinary Shares escrowed until 17/12/2017
		2,498,812 fully pai
		David Jerimiah Mc	Auliffed Ordinary Shares escrowed until 17/12/2017
		7,501,188 fully pai
Class		Fully paid Ordinar	y Shares
Number acquired
		700,000
Number disposed		-
Value/Considerationincludes brokerage/gstNote: If consideration is non-cash, providedetails and estimated valuation		$15,418.62

• See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after	Direct
change	David McAuliffe
	700,000 fully paid Ordinary Shares
	840,825 fully paid Ordinary Shares escrowed until 17/12/2017
	156,763 Class 1 Performance Shares escrowed until 17/2/2017
	Indirect
	Concept Biotech Pty Ltd
	2,498,812 fully paid Ordinary Shares escrowed until 17/12/2017
	David Jerimiah McAuliffe
	7,501,188 fully paid Ordinary Shares escrowed until 17/12/2017
Nature of change	On-market purchase
Example: on-market trade, off-market trade,
exercise of options, issue of securities under
dividend reinvestment plan, participation in
buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder	N/A
(if issued securities)
Date of change	N/A
No. and class of securities to	N/A
which interest related prior to
change
Note: Details are only required for a contract in relation
to which the interest has changed
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration	N/A
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed	No
above traded during a+closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade	N/A
to proceed during this period?
If prior written clearance was provided, on what date was this	N/A
provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2